SEC Form 4 · accession 0001984065-26-000008
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pierre Gravier
Officer — CHIEF FINANCIAL OFFICER
Period of report
Jul 14, 2026
Accepted (ET)
Jul 16, 2026 · 5:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 14, 2026 | S | 3,494 | $80.35 | D | 83,986 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 6,500 RSUs from a July 13, 2023 grant of 26,000 RSUs
- F2Includes 162 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2026.